Krampera M - Search Results

1

Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol.

Vitale A, Guarini A, Ariola C, Mancini M, Mecucci C, Cuneo A, Pane F, Saglio G, Cimino G, Tafuri A, Meloni G, Fabbiano F, Recchia A, Kropp MG, Krampera M, Cascavilla N, Ferrara F, Romano A, Mazza P, Fozza C, Paoloni F, Vignetti M, Foà R. Vitale A, et al. Among authors: krampera m. Blood. 2006 Jan 15;107(2):473-9. doi: 10.1182/blood-2005-04-1754. Epub 2005 Sep 22. Blood. 2006. PMID: 16179376 Free article.

2

Serum level of the soluble form of the CD30 molecule identifies patients with Hodgkin's disease at high risk of unfavorable outcome.

Nadali G, Tavecchia L, Zanolin E, Bonfante V, Viviani S, Camerini E, Musto P, Di Renzo N, Carotenuto M, Chilosi M, Krampera M, Pizzolo G. Nadali G, et al. Among authors: krampera m. Blood. 1998 Apr 15;91(8):3011-6. Blood. 1998. PMID: 9531614 Free article.

3

t(4;11)(q21;p15) translocation involving NUP98 and RAP1GDS1 genes: characterization of a new subset of T acute lymphoblastic leukaemia.

Mecucci C, La Starza R, Negrini M, Sabbioni S, Crescenzi B, Leoni P, Di Raimondo F, Krampera M, Cimino G, Tafuri A, Cuneo A, Vitale A, Foà R. Mecucci C, et al. Among authors: krampera m. Br J Haematol. 2000 Jun;109(4):788-93. doi: 10.1046/j.1365-2141.2000.02106.x. Br J Haematol. 2000. PMID: 10929031 Free article.

4

Outcome prediction by immunophenotypic minimal residual disease detection in adult T-cell acute lymphoblastic leukaemia.

Krampera M, Vitale A, Vincenzi C, Perbellini O, Guarini A, Annino L, Todeschini G, Camera A, Fabbiano F, Fioritoni G, Nobile F, Szydlo R, Mandelli F, Foà R, Pizzolo G. Krampera M, et al. Br J Haematol. 2003 Jan;120(1):74-9. doi: 10.1046/j.1365-2141.2003.03974.x. Br J Haematol. 2003. PMID: 12492579 Free article.

5

A multiplex reverse transcriptase-polymerase chain reaction strategy for the diagnostic molecular screening of chimeric genes: a clinical evaluation on 170 patients with acute lymphoblastic leukemia.

Elia L, Mancini M, Moleti L, Meloni G, Buffolino S, Krampera M, De Rossi G, Foà R, Cimino G. Elia L, et al. Among authors: krampera m. Haematologica. 2003 Mar;88(3):275-9. Haematologica. 2003. PMID: 12651265

6

Methodological approach to minimal residual disease detection by flow cytometry in adult B-lineage acute lymphoblastic leukemia.

Krampera M, Perbellini O, Vincenzi C, Zampieri F, Pasini A, Scupoli MT, Guarini A, De Propris MS, Coustan-Smith E, Campana D, Foà R, Pizzolo G. Krampera M, et al. Haematologica. 2006 Aug;91(8):1109-12. Haematologica. 2006. PMID: 16885052

7

Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways.

Scupoli MT, Donadelli M, Cioffi F, Rossi M, Perbellini O, Malpeli G, Corbioli S, Vinante F, Krampera M, Palmieri M, Scarpa A, Ariola C, Foà R, Pizzolo G. Scupoli MT, et al. Among authors: krampera m. Haematologica. 2008 Apr;93(4):524-32. doi: 10.3324/haematol.12098. Epub 2008 Mar 5. Haematologica. 2008. PMID: 18322253 Free article.

8

Notch-3 and Notch-4 signaling rescue from apoptosis human B-ALL cells in contact with human bone marrow-derived mesenchymal stromal cells.

Nwabo Kamdje AH, Mosna F, Bifari F, Lisi V, Bassi G, Malpeli G, Ricciardi M, Perbellini O, Scupoli MT, Pizzolo G, Krampera M. Nwabo Kamdje AH, et al. Among authors: krampera m. Blood. 2011 Jul 14;118(2):380-9. doi: 10.1182/blood-2010-12-326694. Epub 2011 May 20. Blood. 2011. PMID: 21602525 Free article.

9

Notch signaling in acute lymphoblastic leukemia: any role for stromal microenvironment?

Nwabo Kamdje AH, Krampera M. Nwabo Kamdje AH, et al. Among authors: krampera m. Blood. 2011 Dec 15;118(25):6506-14. doi: 10.1182/blood-2011-08-376061. Epub 2011 Oct 6. Blood. 2011. PMID: 21979940 Free article. Review.

10

Impact of 2016 WHO diagnosis of early and overt primary myelofibrosis on presentation and outcome of 232 patients treated with ruxolitinib.

Palandri F, Palumbo GA, Abruzzese E, Iurlo A, Polverelli N, Elli E, Bonifacio M, Bergamaschi M, Martino B, Tiribelli M, Benevolo G, Tieghi A, Sgherza N, Isidori A, Binotto G, Crugnola M, Heidel F, Cavazzini F, Bosi C, Auteri G, Cattaneo D, Foà R, Lemoli RM, Cuneo A, Krampera M, Bartoletti D, Cavo M, Vianelli N, Breccia M, Latagliata R. Palandri F, et al. Among authors: krampera m. Hematol Oncol. 2019 Oct;37(4):418-423. doi: 10.1002/hon.2619. Epub 2019 Jun 7. Hematol Oncol. 2019. PMID: 30985017

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

198 results

Search Page